NLX 204
Alternative Names: NLX-204Latest Information Update: 28 Feb 2023
At a glance
- Originator Neurolixis
- Class Antidepressants; Non-opioid analgesics; Small molecules
- Mechanism of Action 5-HT1A serotonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Depressive disorders; Pain